Fingerprint
Dive into the research topics of 'Two year follow-up of Crohn's patients substituted to certolizumab anti-TNFa therapy: SAVANT 2'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Two year follow-up of Crohn's patients substituted to certolizumab anti-TNFa therapy: SAVANT 2
Andrew Motlis, Moheb Boktor, Paul Jordan, Urska Cvek, Marjan Trutschl, J. Steven Alexander
Research output: Contribution to journal › Article › peer-review
3
Scopus
citations